Horizon Pharma (HZNP) PT Raised to $18 at BMO Capital on 2Q Beat; 'Nice Reovery in 2Q... Raised Guidance Appears Conservative'
Tweet Send to a Friend
BMO Capital raised its price target on Horizon Pharma (NASDAQ: HZNP) to $18.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
